Lack of relationship between obesity and mortality or morbidity after coronary artery bypass grafting

Tom Kai Ming Wang1, Tharumenthiran Ramanathan, Ralph Stewart

  • 1Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, Victoria St West, Auckland 1142, New Zealand. HarveyW@adhb.govt.nz.

Insights

Obesity is common in coronary artery bypass grafting (CABG) patients, but body mass index (BMI) categories did not affect mortality or morbidity. These findings suggest obesity is not a risk factor for adverse CABG outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Obesity Research
  • Surgical Outcomes

Background:

  • Obesity presents significant cardiovascular risks.
  • Existing data on body mass index (BMI) and coronary artery bypass grafting (CABG) outcomes are conflicting.
  • Understanding BMI's impact on CABG patients is crucial for surgical decision-making.

Purpose of the Study:

  • To compare the outcomes of coronary artery bypass grafting (CABG) patients across different body mass index (BMI) categories.
  • To investigate whether obesity is associated with increased mortality or morbidity after CABG.

Main Methods:

  • Retrospective analysis of isolated CABG patients from July 2010 to June 2012.
  • Patients were categorized into four BMI groups: normal (≤25 kg/m²), overweight (>25-30 kg/m²), obese (>30-35 kg/m²), and morbidly obese (>35 kg/m²).
  • Outcomes including 30-day mortality, composite morbidity, and long-term survival were compared across groups.

Main Results:

  • Increasing BMI correlated with younger age and higher creatinine clearance.
  • Obesity was linked to higher rates of Maori/Pacific ethnicity and hypertension.
  • Morbid obesity was associated with female sex, higher deprivation index, diabetes, longer operation times, and sternal wound infection.
  • Crucially, 30-day mortality, composite morbidity, and survival rates were similar across all BMI categories.

Conclusions:

  • Over a third of CABG patients were overweight or obese, with 13% being morbidly obese.
  • Contrary to some expectations, obesity was not found to be a risk factor for adverse outcomes after CABG.
  • These results indicate that obesity should not be considered a contraindication for CABG surgery.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620